John Lansing's Trending123
John Lansing's Trending123
Username: Password: Login
Trade Talk E-Letter Products & Services Trading Tools Portfolios Members Home
Enter Symbol:
AVANIR PHARMACEUTICALS
Drug Manufacturers Other
AVNR @ Yahoo Finance
AVNR Option @ Yahoo Finance
Stock Details
Current Price High Value Change Percent Change Dividend Previous Close
$ 0.90 $ 0.94 $ 0.02 2.27% 0.00 $ 0.88
Opening Price Low Volume Market Cap Average Volume P/E
$ 0.88 $ 0.88 75,450 70.38M 110,484.5 90.00
Pivot Table
R2 R1 Pivot S1 S2
0.97 0.94 0.91 0.88 0.85

stock chart

Avanir Pharmaceuticals, a pharmaceutical company, focuses on developing, acquiring, and commercializing therapeutic products for the treatment of chronic diseases. Its products and product candidates address therapeutic markets, including the central nervous system, inflammation, and infectious diseases. The company's lead product candidate Zenvia is being developed for the treatment of pseudobulbar affect (PBA), also known as involuntary emotional expression disorder. Zenvia also completed Phase III clinical trial in patients with diabetic peripheral neuropathic (DPN) pain. Avanir's infectious disease drug candidate, AVP-21D9 is a human monoclonal antibody that is in pre-clinical development for the treatment of anthrax. The company has also licensed a compound to Novartis International Pharmaceutical, Ltd. for the treatment of inflammatory disease. In addition, the company's commercialized product, Abreva is an over-the-counter product for the treatment of cold sores and is marketed in North America by GlaxoSmithKline Consumer Healthcare. Further, it is using its Xenerex technology to develop human monoclonal antibodies for use as prophylactic and therapeutic drugs to prevent and treat anthrax and other infectious diseases. The company was founded in 1988 and is headquartered in Aliso Viejo, California.

  • Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
  • Provide you stock picks (breakouts) and market direction to help you become
    more profitable.

  • Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
  • Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
  • Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More